These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23206977)

  • 1. The contribution of thyroid dysfunction on cardiovascular disease in patients with chronic kidney disease.
    Tatar E; Kircelli F; Ok E
    Atherosclerosis; 2013 Mar; 227(1):26-31. PubMed ID: 23206977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid diseases, dyslipidemia and cardiovascular pathology.
    Neves C; Alves M; Medina JL; Delgado JL
    Rev Port Cardiol; 2008 Oct; 27(10):1211-36. PubMed ID: 19178025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid disease and the heart.
    Klein I; Danzi S
    Circulation; 2007 Oct; 116(15):1725-35. PubMed ID: 17923583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid disease and the cardiovascular system.
    Danzi S; Klein I
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):517-28. PubMed ID: 24891175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of endothelial dysfunction in chronic kidney disease.
    Malyszko J
    Clin Chim Acta; 2010 Oct; 411(19-20):1412-20. PubMed ID: 20598675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
    Rammos C; Hendgen-Cotta UB; Sobierajski J; Adamczyk S; Hetzel GR; Kleophas W; Dellanna F; Kelm M; Rassaf T
    Int J Cardiol; 2013 Oct; 168(6):5249-56. PubMed ID: 23978362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones and arterial stiffness in patients with chronic kidney disease.
    Gungor O; Kircelli F; Voroneanu L; Covic A; Ok E
    J Atheroscler Thromb; 2013; 20(9):698-707. PubMed ID: 23911970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Between Rho(k) and a hard place: the relation between vessel wall stiffness, endothelial contractility, and cardiovascular disease.
    Huveneers S; Daemen MJ; Hordijk PL
    Circ Res; 2015 Feb; 116(5):895-908. PubMed ID: 25722443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial stiffness in chronic kidney disease: a modifiable cardiovascular risk factor?
    Pickup L; Radhakrishnan A; Townend JN; Ferro CJ
    Curr Opin Nephrol Hypertens; 2019 Nov; 28(6):527-536. PubMed ID: 31361609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of arterial damage by noninvasive peripheral arterial tonometry in non-diabetic hemodialysis patients].
    Espinoza F; Kunstmann S; Urzúa A; Michea L; Marusic ET; Vukusich A
    Rev Med Chil; 2012 Feb; 140(2):153-60. PubMed ID: 22739943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations.
    Vargas F; Rodríguez-Gómez I; Vargas-Tendero P; Jimenez E; Montiel M
    J Endocrinol; 2012 Apr; 213(1):25-36. PubMed ID: 22043064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric CKD and cardiovascular disease.
    Safder O; Al sharif S; Kari JA
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):177-84. PubMed ID: 24720458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid gland and pulmonary hypertension. What's the link?
    Marvisi M; Balzarini L; Mancini C; Mouzakiti P
    Panminerva Med; 2013 Mar; 55(1):93-7. PubMed ID: 23474667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease.
    Baaten CCFMJ; Vondenhoff S; Noels H
    Circ Res; 2023 Apr; 132(8):970-992. PubMed ID: 37053275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Affection of cardiovascular system in diabetic patients with thyroid dysfunctions].
    Schroner Z; Lazúrová I
    Vnitr Lek; 2006 Nov; 52(11):1069-76. PubMed ID: 17165527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine alterations and cardiovascular risk in CKD: is there a link?
    Ros S; Carrero JJ
    Nefrologia; 2013; 33(2):181-7. PubMed ID: 23511754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
    Gusbeth-Tatomir P; Covic A
    Kidney Blood Press Res; 2007; 30(2):97-107. PubMed ID: 17374960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid disorders and their relevance to outcomes in chronic kidney disease.
    Vaziri ND; Norris K
    Blood Purif; 2011; 31(1-3):189-96. PubMed ID: 21228589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular dysfunction in Cardiorenal Syndrome type 4].
    Sessa C; Granata A; Gaudio A; Xourafa A; Malatino L; Lentini P; Fatuzzo P; Rapisarda F; Castellino P; Zanoli L
    G Ital Nefrol; 2020 Feb; 37(1):. PubMed ID: 32068357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.